Rheumnow Podcast

Discover groundbreaking insights from the ACR Annual Meeting, highlighting the latest in rheumatology research. Explore the complexities of managing difficult axial spondyloarthritis and the nuances in treatment options for psoriatic arthritis. Delve into the promising yet costly advancements in CAR T cell therapy. Learn about intriguing gender differences in biologics efficacy for AXPA patients. Finally, uncover the vital role of imaging in managing giant cell arteritis, revealing the challenges in aligning clinical decisions with patient scans.

Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova Apremilast Benefits and Risks in PsA:Dr. Akhil Sood  Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro Assessment and management of axSpA:Dr. Antoni Chan Disease Activity in RA-ILD:Dr. Richard Conway Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy Highlights in axSpA:Dr. Marina Magrey Hot Topics in axSpA:Dr. Marina Magrey Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr.  Antoni Chan interviews Dr. Catherine Bakewell PsA Potpourri:Dr. Arthur Kavanaugh RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan  Kay interviews Dr. Cécile Gaujoux-Viala RA: One JAK to Rule Them All?:Dr. Brian Jaros What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych  

Dive into the latest on rheumatic diseases, starting with the fast-acting benefits of JAK inhibitors compared to TNF inhibitors. Discover paroxynase-1 as a potential predictor for arthritis progression. Weight loss drugs are making waves in psoriatic arthritis treatment, but is their effect sustainable? Explore how gender influences disease activity measures, and learn about upadacitinib's success in treating giant cell arteritis while tackling the complexities of CAR-T therapies. It's a treasure trove of insights!

Dive into the fascinating developments from ACR Convergence 2024! Discover the pressing need for improved monitoring in scleroderma-associated lung disease. Uncover insights into the survival rates of lung cancer patients with rheumatoid arthritis, showing no significant mortality difference. Explore the implications of tapering prednisone in granulomatosis with polyangiitis, highlighting crucial flare rate findings. Lastly, learn how ACR is evolving its educational practices through digital tools and social media, enhancing collaboration and knowledge-sharing.

ACR 2024 starts tomorrow; here are a few previews of Abstracts to be presented. Along with my recommendations of sessions you don’t want to miss.  

Dr. Jack Cush reviews the news and journal reports from this past week from RheumNow.com

Minimizing steroid use in patients with SLE. Learn more about when, why, and how to taper steroids and listen to experts, Dr Michelle Petri and Dr Leanna Wise, discuss key data and their clinical perspectives on these topics. 

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com Register now for RheumNow.live 2025

This week, Jonathan is joined by John J Cush, from Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine.